RHYTHM Biosciences Ltd (RHY) — Capital Reinvestment Ratio

Latest as of December 2024: 0.00x

RHYTHM Biosciences Ltd (RHY) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow (AU$970.03K) in capital expenditures (AU$5.00). See how leveraged is RHYTHM Biosciences Ltd's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

AU$970.03K

AUD

Capital Expenditures

AU$5.00

AUD

Data as of

Dec 2024

Most recent filing

Annual Capital Reinvestment Ratio for RHYTHM Biosciences Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for RHYTHM Biosciences Ltd from None to None. For live market cap and broader valuation context, see RHYTHM Biosciences Ltd market cap and net worth.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow